Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$2.05 - $2.9 $333,969 - $472,444
-162,912 Reduced 62.63%
97,197 $245,000
Q2 2023

Aug 14, 2023

BUY
$2.76 - $4.72 $717,900 - $1.23 Million
260,109 New
260,109 $1.14 Million

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $213M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Corbin Capital Partners, L.P. Portfolio

Follow Corbin Capital Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corbin Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Corbin Capital Partners, L.P. with notifications on news.